IMPARP-HRD Statistical Analysis Plan
收藏数据链接：
官方服务：
资源简介：
This document presents the statistical analysis plan for the study 'IMPARP-HRD', a multi-centre, signle arm, signal seeking, phase II study designed to evaluate the efficacy and safety of pamiparib and tislelizumab in patients with locally recurrent, incurable or metastatic solid cancer of any histological type.
创建时间：
2025-05-26
相关数据集
暂无相关数据集
